Results 71 to 80 of about 20,777 (183)

Vareniclina y bupropión: ¿eficaces para el tratamiento del trastorno por uso de alcohol?

open access: yes
La vareniclina redujo el consumo de alcohol en adultos con TUA independientemente del estado tabáquico, pero no fue eficaz en el TUA grave. La combinación de bupropión con vareniclina no aumentó la eficacia, pero redujo significativamente la frecuencia y
David A. Gorelick
core   +1 more source

Charcoal hemoperfusion in bupropion overdose

open access: yesJournal of the Formosan Medical Association, 2014
Bupropion is a relatively new and popular medication for depression, with seizures as its major side effect. In the literature, there are insufficient data about hemodialysis following bupropion overdose.
Hızır Ufuk Akdemir   +5 more
doaj   +1 more source

Peripheral targets for neuropathic pain

open access: yesBritish Journal of Pharmacology, EarlyView.
Neuropathic pain represents a significant clinical challenge, with still limited pharmacological approaches to symptomatic relief. This review focuses on molecular targets implicated in neuropathic pain, particularly those involved in peripheral mechanisms. Using the IUPHAR/BPS database of biological targets, their occurrence together with ‘neuropathic
Amirhossein Afsharipour   +3 more
wiley   +1 more source

Alternativas a un SSRI como opción de primera línea

open access: yes, 2018
Si los riesgos de efectos adversos de un SSRI son inaceptables, existen otras opciones a considerar (no necesariamente en orden de preferencia): Duloxetina (preferida sobre la venlafaxina ) Buspirona Hidroxizina Pregabalina ...
Mercedes Guaia Memita Guaia
core   +1 more source

The real‐world relationship between naltrexone/bupropion treatment and weight loss in Canada: A retrospective chart review

open access: yesClinical Obesity, Volume 15, Issue 2, April 2025.
Summary This study examined the change in weight at 6 months of naltrexone/bupropion (NB), a combination pharmacological therapy for weight management, in real‐world practice in Canada. The study was conducted through an observational, retrospective, single‐arm chart review of adult patients who attended the Wharton Medical Clinic in Ontario, Canada ...
Sean Wharton   +4 more
wiley   +1 more source

Prolongación del QTc – otros antidepresivos

open access: yes, 2019
No existe evidencia sólida de prolongación del QT clínicamente significativa con otros antidepresivos. El bupropión puede causar taquicardia en caso de sobredosis.
Mercedes Guaia Memita Guaia
core   +1 more source

Effect of increasing intraperitoneal infusion rates on bupropion hydrochloride-induced seizures in mice

open access: yesAnnals of General Psychiatry, 2008
Background It is not known if there is a relationship between input rate and incidence of bupropion-induced seizures. This is important, since different controlled release formulations of bupropion release the active drug at different rates.
Fleming Rosanna   +4 more
doaj   +1 more source

Preferences for Obesity Medications Among People With Overweight or Obesity in the United States: A Discrete‐Choice Experiment (OPTIC)

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims To evaluate the relative importance of attributes driving obesity medication (OM) choice and preferences among individuals with overweight or obesity. Materials and Methods US adults with obesity or overweight and ≥ 1 obesity‐related complication completed an online survey including a discrete‐choice experiment (DCE) in October–November ...
Jaime P. Almandoz   +7 more
wiley   +1 more source

Efectos del bupropión sobre depresión, ansiedad y abstinencia a nicotina

open access: yes, 2017
Los trastornos de ansiedad y depresión tienen alta prevalencia a nivel mundial y notablemente ocurre comorbilidad entre trastornos afectivos y de ansiedad con el consumo de tabaco; en efecto, quienes padecen alteraciones del estado de ánimo son más ...
Contreras, Carlos   +3 more
core  

Estimulantes consideraciones clínicas, abuso y signos de alarma

open access: yes, 2020
Antes de prescribir estimulantes, evalúe la presencia de un trastorno por uso de sustancias (TUS) activo o antecedentes del mismo. Esté atento a las señales de alerta que sugieran posible abuso o desviación de estimulantes.
Mercedes Guaia Memita Guaia
core   +1 more source

Home - About - Disclaimer - Privacy